Elutia, Inc. (ELUT)
0.8392
+0.02
(+2.34%)
USD |
NASDAQ |
Nov 16, 13:38
Elutia Total Liabilities (Quarterly) : 32.87M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 32.87M |
| June 30, 2026 | 27.90M |
| March 31, 2026 | 32.68M |
| December 31, 2025 | 34.68M |
| September 30, 2025 | 73.32M |
| June 30, 2025 | 75.69M |
| March 31, 2025 | 75.76M |
| December 31, 2024 | 82.39M |
| September 30, 2024 | 88.64M |
| June 30, 2024 | 106.24M |
| March 31, 2024 | 85.66M |
| December 31, 2023 | 82.03M |
| September 30, 2023 | 84.05M |
| Date | Value |
|---|---|
| June 30, 2023 | 74.46M |
| March 31, 2023 | 72.80M |
| December 31, 2022 | 73.87M |
| September 30, 2022 | 71.70M |
| June 30, 2022 | 54.22M |
| March 31, 2022 | 53.37M |
| December 31, 2021 | 53.65M |
| September 30, 2021 | 52.04M |
| June 30, 2021 | 54.74M |
| March 31, 2021 | 57.76M |
| December 31, 2020 | 61.98M |
| September 30, 2020 | 121.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 357.70M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 52.02M |
| BioCryst Pharmaceuticals, Inc. | 988.45M |
| Imunon, Inc. | 9.386M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 48.19M |
| Shareholders Equity (Quarterly) | 15.32M |
| Debt to Equity Ratio | 1.046 |
| Current Ratio | 2.630 |
| Net Debt Paydown Yield | 12.15% |